Document Detail


A chromogenic assay for activated protein C resistance.
MedLine Citation:
PMID:  7669667     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Resistance to activated protein C (APC) diagnosed on the basis of prolongation of clotting time in an activated partial thromboplastin time (aPTT) assay is now considered a major cause of inherited thrombophilia. The majority of patients with APC resistance carry a factor V molecule with a point mutation at one APC cleavage site (Arg506Gln) which prevents the optimal inactivation of activated factor V by APC. To overcome the limitations of aPTT-based assays in the diagnosis of APC resistance, we have developed a chromogenic assay which is based on the capacity of APC to limit the generation of factor Xa by inactivating factor VIIIa in plasma. The ratio of the factor Xa amidolytic activity in a sample without APC to its factor Xa activity with the addition of APC reflects the response of the plasma coagulation system to APC. The normal range in 44 healthy individuals was 1.62-2.06. APC response ratios as measured by the chromogenic assay correlated with ratios measured by the aPTT assay and were below the normal range in 23/24 individuals with Arg506Gln mutant factor V from three different families with familial thrombosis and from 11 unrelated asymptomatic individuals. In reconstitution experiments, purified factor V corrected the decreased APC response in plasma samples from patients with the Arg506Gln mutation as well as with factor V deficiency, and increased the APC response in normal plasma, whereas the addition of activated factor V had no enhancing effect.
Authors:
K Váradi; B Moritz; H Lang; K Bauer; E Preston; I Peake; G E Rivard; B Keil; H P Schwarz
Related Documents :
17413817 - Correlates of physical activity in adults with mobility limitations.
17325117 - Physical activity preferences and perceived barriers to activity among persons with sev...
6422977 - Haemostatic and fibrinolytic properties of peritoneal fluid in the menstrual cycle.
12471307 - Correlates of adults' participation in physical activity: review and update.
2384417 - Effect of exercise intensity and duration on postexercise metabolism.
22240377 - Preliminary findings in the heart rate variability and haemorheology response to varied...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  90     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  1995 Aug 
Date Detail:
Created Date:  1995-10-18     Completed Date:  1995-10-18     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  884-91     Citation Subset:  IM    
Affiliation:
Research Laboratories of Immuno AG, Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / metabolism
Blood Coagulation
Chromogenic Compounds / diagnostic use
Factor V / genetics,  metabolism
Factor VIII / metabolism
Factor Va / metabolism
Female
Humans
Male
Mutation
Protein C / metabolism*
Reference Values
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Chromogenic Compounds; 0/Protein C; 65522-14-7/Factor Va; 9001-24-5/Factor V; 9001-27-8/Factor VIII

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transduction of MDR1 into human and mouse haemopoietic progenitor cells: use of rhodamine (Rh123) to...
Next Document:  Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients ...